Skip to main content
GE enters licensing deal on asymptomatic malaria detection
7/13/2017

GE, the Global Good Fund and Access Bio will make and distribute rapid diagnostic technologies for asymptomatic malaria detection in low-resource countries under a licensing deal. The agreement also covers a technology that supports the creation of malarial serology tests for Plasmodium antibodies, as well as Plasmodium lactate dehydrogenase rapid diagnostic tests for malarial parasite detection and a highly sensitive diagnostic test for identification of malaria-related proteins.

Full Story: